AG

Alexandr Grachev

Deputy CEO

BIOCAD


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
BIOCAD
Industry
pharmaceuticals
Employees
830.0
Seniority
C suite

Professional Summary

Alexandr Grachev serves as Deputy CEO at BIOCAD. BIOCAD operates in the pharmaceuticals sector with approximately 830.0 employees.

Industry & Role Insights

  • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
  • Our database includes 201,468 c suite-level executives.

Technologies

Microsoft Office 365 Outlook Salesforce Grafana Microsoft Azure Monitor Jira Atlassian Confluence React Redux Citrix NetScaler Micro

Keywords

pharmaceutical biotechnology science r d research pharma it bioinformatics pharmaceutical manufacturing drug development biologics biosimilars oncological diseases autoimmune diseases gene therapy clinical trials innovative therapies healthcare solutions patient well-being sustainability research & development therapeutic proteins market expansion international operations healthcare providers genetic disorders cancer treatment spinal muscular atrophy hemophilia therapeutic focus ethical standards quality compliance life sciences commercial-scale manufacturing drug discovery therapeutic innovation patient demographics healthcare systems social impact clinical research therapeutic areas advanced therapies market strategy patient accessibility healthcare challenges drug registration therapeutic effectiveness medical information technology & services pharmaceuticals health care health wellness & fitness hospital & health care environmental services renewables & environment

Related Executives

YM
Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions
RB
Ronan Brown Chief Operating Officer at 4G Clinical
HK
Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation
LJ
Lars Jensen CEO at A-apoteket
TL
Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Alexandr Grachev in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at BIOCAD.

Alexandr Grachev's Position in the MessageCEO Database

  • Alexandr Grachev is 1 of 1 verified executive contact we track at BIOCAD.
  • 1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
  • 5 verified contacts work at pharmaceuticals companies in the 830.0 employee range (same size as BIOCAD).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

Frequently Asked Questions

How do I reach Alexandr Grachev directly?

Alexandr Grachev's verified email address is available to MessageCEO Pro subscribers. They currently serve as Deputy CEO at BIOCAD. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Alexandr Grachev work for?

Alexandr Grachev is Deputy CEO at BIOCAD, a company in the pharmaceuticals sector with 830.0 employees.

Can I pitch or sell to Alexandr Grachev?

As Deputy CEO at BIOCAD, Alexandr Grachev is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Alexandr Grachev directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Alexandr Grachev in?

Alexandr Grachev works in the pharmaceuticals industry as Deputy CEO at BIOCAD. MessageCEO provides verified contact information for executives across all major industries.

Is Alexandr Grachev's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Alexandr Grachev's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: July 26, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans